MENU

 Education

School — Major — Degree Duration

國立陽明大學 — 醫學系(畢) — 學士

Bachelor,  ,  

2001/08 — 2008/06

 Intramural Experience

Office/Department/Institute Position Duration
胸腔內科 Division of Thoracic Medicine   Visiting Staff   —  
學士後醫學系 School of Post-Baccalaureate Medicine   Assistant Professor 2023/08/01 —  

 Extramural Experience

 

 Discipline

 

 Research & Technology Platform Open to the Outside

 

 Interested Area(s)for Interdisciplinary Research

 

 

 Area(s) of Expertise & Research

肺癌、胸腔醫學

Lung cancer, Pulmonology

 Publication

NO Publication
1

First-Line Afatinib 30 mg 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan.
洪會洋, 李岱晃, 莊政皓, 李玫萱, 吳寬澧, 郭家佑, 黃虹綾, 黃鍾文, 蔡毓真, 洪仁宇, 鍾飲文, 楊志仁* - - 1 - ANTICANCER RESEARCH - ANTICANCER RESEARCH 2026 46卷(2期):917-938頁
(IF: 1.8, 領域排名: 264, 領域期刊數: 333, 領域排名: 79.28%)

First-Line Afatinib 30 mg 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan.
Hui-Yang Hung, Tai-Huang Lee, Cheng-Hao Chuang, Mei-Hsuan Lee, Kuan-Li Wu, Chia-Yu Kuo, Hung-Ling Huang, Chung-Wen Huang, Yu-Chen Tsai, Jen-Yu Hung, Inn-Wen Chong, Chih-Jen Yang* - - 1 - ANTICANCER RESEARCH - ANTICANCER RESEARCH 2026;46(2):917-938
(IF: 1.8, Journal Ranking: 264, Number of Journals of this Field: 333, Ranking: 79.28%)

2

Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer.
郭家佑,黃天祈, 楊志仁,李玫萱, 李瑞英, 蔡英明, 吳寬澧, 莊政皓,鍾飲文, 洪仁宇* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2026 42卷(3期):e70105頁
(IF: 3.1, 領域排名: 92, 領域期刊數: 191, 領域排名: 48.17%)

Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer.
Chia-Yu Kuo, Tien-Chi Huang, Chih-Jen Yang, Mei-Hsuan Lee, Jui-Ying Lee, Ying-Ming Tsai, Kuan-Li Wu, Cheng-Hao Chuang, Inn-Wen Chong, Jen-Yu Hung - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2026;42(3):e70105
(IF: 3.1, Journal Ranking: 92, Number of Journals of this Field: 191, Ranking: 48.17%)

3

Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma.
姜宏興, 翁采彤, 張昭元,吳寬澧,吳宇瑗, 賴佳辰, 沈子彥,洪仁宇,李孝貞,蔡英明*, 許雅玲 - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(2期):854-868頁
(IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%)

Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma.
Hung-Hsing Chiang, Chai-Tung Ong, Chao-Yuan Chang, Kuan-Li Wu, Yu-Yuan Wu, Jia-Chen Lai, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ying-Ming Tsai, Ya-Ling Hsu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(2):854-868
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

4

Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma.
蔡英明, 吳寬澧,黃永麒 Yu-Yuan Wu, Chao-Yuan Chang, 張永裕, 姜宏興, 劉伶秀, 洪仁宇* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024 29卷(1期):9頁
(IF: 3.4, 領域排名: 76, 領域期刊數: 189, 領域排名: 40.21%)

Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma.
Ying-Ming Tsai, Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Jen-Yu Hung* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024;29(1):9
(IF: 3.4, Journal Ranking: 76, Number of Journals of this Field: 189, Ranking: 40.21%)

5

Intestinal capillariasis: An indigenous case in Taiwan.
李威德,Chih-Lin Huang, 林榮峙, 陳昭儒, 吳寬澧, 李俊德, 蘇月秋* - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2024 57卷(2024期):520-522頁
(IF: 4.5, 領域排名: 40, 領域期刊數: 161, 領域排名: 24.84%)

Intestinal capillariasis: An indigenous case in Taiwan.
Wei-Te Lee, Chih-Lin Huang, Rong-Jyh Lin, Chao-Ju Chen, Kuan-Li Wu, June-Der Lee, Yue-Chiu Su - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2024;57(2024):520-522
(IF: 4.5, Journal Ranking: 40, Number of Journals of this Field: 161, Ranking: 24.84%)

6

PROM2上調在肺鱗狀細胞癌中促進癌細胞移行並導致不良預後
吳寬澧, 張昭元, 蔡英明, 賴佳辰, 洪仁宇, 林依宣, 蔡佩薰, 許雅玲* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(4期):1561-1576頁
(IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%)

PROM2 upregulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma.
Kuan-Li Wu, Chao-Yuan Chang, Ying-Ming Tsai, Jia-Chen Lai, Jen-Yu Hung, Yi-Shiuan Lin, Pei-Hsun Tsai, Ya-Ling Hsu* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(4):1561-1576
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

7

Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing.
戴嘉言, 蔡英明, 張昭元, 蔡鴻培, 吳寬澧, 吳宇瑗, Ling-Yu Wu, 簡淑芳, 蔡珮熏, 翁采彤, Chien-Hui Sun, 許雅玲* - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024 20卷(14期):5531-5547頁
(IF: 8.2, 領域排名: 31, 領域期刊數: 313, 領域排名: 9.90%)

Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing.
Chia-Yen Dai, Ying-Ming Tsai, Chao-Yuan Chang, Hung-Pei Tsai, Kuan-Li Wu, Yu-Yuan Wu, Ling-Yu Wu, Shu-Fang Jian, Pei-Hsun Tsai, Chai-Tung Ong, Chien-Hui Sun, Ya-Ling Hsu* - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024;20(14):5531-5547
(IF: 8.2, Journal Ranking: 31, Number of Journals of this Field: 313, Ranking: 9.90%)

8

Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma.
姜宏興, 吳寬澧, 蔡鴻培, 翁采彤, 張昭元, 吳宇瑗, 沈子晏, 洪仁宇, 李孝貞, 許雅玲, 蔡英明* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(10期):4817-4829頁
(IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%)

Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma.
Hung-Hsing Chiang, Kuan-Li Wu, Hung-Pei Tsai, Chai-Tung Ong, Chao-Yuan Chang, Yu-Yuan Wu, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ya-Ling Hsu, Ying-Ming Tsai* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(10):4817-4829
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

9

Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.
郭家佑, 蔡明儒, 洪仁宇, 李玫萱, 吳寬澧, 蔡毓真, 莊政皓, 黃鍾文, Chin-Ling Chen,楊志仁*, 鍾飲文 - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40卷(5期):467-476頁
(IF: 2.7, 領域排名: 95, 領域期刊數: 189, 領域排名: 50.26%)

Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, Kuan-Li Wu, Yu-Chen Tsai, Cheng-Hao Chuang, Chung-Wen Huang, Chin-Ling Chen, Chih-Jen Yang*, Inn-Wen Chong - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(5):467-476
(IF: 2.7, Journal Ranking: 95, Number of Journals of this Field: 189, Ranking: 50.26%)

10

A rare case of tracheal squamous cell carcinoma presented with critical airway obstruction
何晨宇, 劉又瑋, 賴薇安, 陳家閔, 吳寬澧* - - A - Respirology Case Reports - RESPIROLOGY CASE REPORTS 2024 12卷(9期):e70024頁
(IF: 0.8, 領域排名: 88, 領域期刊數: 100, 領域排名: 88.00%)

A rare case of tracheal squamous cell carcinoma presented with critical airway obstruction
Chen-Yu Ho, Yu-Wei Liu, Wei-An Lai, Chia-Min Chen, Kuan-Li Wu - - A - Respirology Case Reports - RESPIROLOGY CASE REPORTS 2024;12(9):e70024
(IF: 0.8, Journal Ranking: 88, Number of Journals of this Field: 100, Ranking: 88.00%)

11

LAD1透過促進肺腺癌增生和增加侵襲性縮短肺癌患者存活
張昭元, 黃永琪, 姜宏興, 吳宇瑗, 吳寬澧, 張永裕, 劉伶琇, 蔡英明*, 許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023 24卷(1期):431頁
(IF: 5.6, 領域排名: 66, 領域期刊數: 285, 領域排名: 23.16%)

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023;24(1):431
(IF: 5.6, Journal Ranking: 66, Number of Journals of this Field: 285, Ranking: 23.16%)

12

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.
郭家佑, 蔡明儒, 洪仁宇, 吳寬澧, 蔡英明, 蔡毓真, 莊政皓, 李岱晃, 陳煌麒, 楊志仁*, 鍾飲文* - - 1 - CANCERS - CANCERS 2023 15卷(1期):187頁
(IF: 5.2, 領域排名: 72, 領域期刊數: 241, 領域排名: 29.88%)

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yu-Chen Tsai, Cheng-Hao Chuang, Tai-Huang Lee, Huang-Chi Chen, Chih-Jen Yang, Inn-Wen Chong - - 1 - CANCERS - CANCERS 2023;15(1):187
(IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%)

13

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with -Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.
蔡明儒, 洪仁宇, 馬瑞陽, 蔡毓真, 吳寬澧, 李玫萱, 郭家佑, 莊政皓, 李岱晃, 李彥龍, 黃鈞民, 沈玫秋, 楊志仁*, 鍾飲文* - - 1 - CANCERS - CANCERS 2023 15卷(7期):2019頁
(IF: 5.2, 領域排名: 72, 領域期刊數: 241, 領域排名: 29.88%)

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with -Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.
Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma, Yu-Chen Tsai, Kuan-Li Wu, Mei-Hsuan Lee, Chia-Yu Kuo, Cheng-Hao Chuang, Tai-Huang Lee, Yen-Lung Lee, Chun-Ming Huang, Mei-Chiou Shen, Chih-Jen Yang, Inn-Wen Chong - - 1 - CANCERS - CANCERS 2023;15(7):2019
(IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%)

14

LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.
吳寬澧,蔡英明,黃永琪,吳宇瑗,張昭元,劉又瑋,許雅玲,洪仁宇* - - 1 - THORACIC CANCER - THORACIC CANCER 2023 14卷(4期):407-418頁
(IF: 2.9, 領域排名: 43, 領域期刊數: 66, 領域排名: 65.15%)

LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.
Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yu-Wei Liu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - THORACIC CANCER - THORACIC CANCER 2023;14(4):407-418
(IF: 2.9, Journal Ranking: 43, Number of Journals of this Field: 66, Ranking: 65.15%)

15

利用單細胞定序技術特徵化肋膜微環境
吳宇瑗, 許雅玲*, 黃詠琪, 蘇秋月, 吳寬澧, 張昭元, 翁采彤, 賴佳辰, 沈子宴, 洪仁宇, 蔡英明* - - 1 - THERANOSTICS - THERANOSTICS 2023 13卷(13期):4412-4429頁
(IF: 12.4, 領域排名: 8, 領域期刊數: 136, 領域排名: 5.88%)

Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer
Wu YY, Hsu YL*, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM* - - 1 - THERANOSTICS - THERANOSTICS 2023;13(13):4412-4429
(IF: 12.4, Journal Ranking: 8, Number of Journals of this Field: 136, Ranking: 5.88%)

16

Cysteinyl Leukotriene Pathway and Cancer.
蔡明儒,張維安,莊政皓,吳寬澧,鄭至宏,許超群,許雅玲,洪仁宇* - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022 23卷(1期):120頁
(IF: 6.208, 領域排名: 69, 領域期刊數: 296, 領域排名: 23.31%)

Cysteinyl Leukotriene Pathway and Cancer.
Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022;23(1):120
(IF: 6.208, Journal Ranking: 69, Number of Journals of this Field: 296, Ranking: 23.31%)

17

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
蔡毓真,陳筱伶#,李岱晃,張秀美,吳寬澧,莊政皓,張詠婕,杜裕康,洪仁宇,楊志仁*,鍾飲文* - - 2 - cancers - CANCERS 2022 14卷(1期):182頁
(IF: 6.575, 領域排名: 60, 領域期刊數: 245, 領域排名: 24.49%)

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
Yu-Chen Tsai , Hsiao-Ling Chen, Tai-Huang Lee , Hsiu-Mei Chang , Kuan-Li Wu , Cheng-Hao Chuang , Yong-Chieh Chang , Yu-Kang Tu , Jen-Yu Hung , Chih-Jen Yang , Inn-Wen Chong - - 2 - cancers - CANCERS 2022;14(1):182
(IF: 6.575, Journal Ranking: 60, Number of Journals of this Field: 245, Ranking: 24.49%)

18

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma.
李孝貞, 張昭元#, 黃永麒, 吳寬澧, 姜宏興, 張永裕, Lian-Xiu Liu, 洪仁宇, 許雅玲, Yu-Yuan Wu, 蔡英明* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11卷(5期):760頁
(IF: 5.168, 領域排名: 21, 領域期刊數: 94, 領域排名: 22.34%)

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma.
Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, 吳寬澧, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(5):760
(IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%)

19

Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis
李岱晃,陳筱伶#,張秀美,吳秋玫,吳寬澧,莊政皓,郭家佑,魏伯儒,陳金鈴,劉憓陵,洪仁宇,楊志仁*,鍾飲文* - - 1 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2022 11卷(12期):3366頁
(IF: 4.964, 領域排名: 54, 領域期刊數: 172, 領域排名: 31.40%)

Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis
Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Jen-Yu Hung, Chih-Jen Yang, Inn-Wen Chong - - 1 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2022;11(12):3366
(IF: 4.964, Journal Ranking: 54, Number of Journals of this Field: 172, Ranking: 31.40%)

20

The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.
李孝貞, 張昭元#, 吳寬澧, 姜宏興, 張永裕, Lian-Xiu Liu, 黃永麒, 洪仁宇, 許雅玲, Yu-Yuan Wu, 蔡英明* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022 12卷(6期):902頁
(IF: 3.508, 領域排名: 41, 領域期刊數: 109, 領域排名: 37.61%)

The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.
Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Yung-Chi Huang, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022;12(6):902
(IF: 3.508, Journal Ranking: 41, Number of Journals of this Field: 109, Ranking: 37.61%)

21

Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.
吳寬澧, 黃永麒, Yu-Yuan Wu, 張昭元, 張永裕, 姜宏興, Lian-Xiu Liu, 蔡英明, 洪仁宇* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11卷(7期):975頁
(IF: 5.168, 領域排名: 21, 領域期刊數: 94, 領域排名: 22.34%)

Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.
Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(7):975
(IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%)

22

Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.
許恩齊, 吳寬澧, 蔡英明, 李玫萱, 蔡明儒, 郭家佑, Yu-Chuan Liu, Fu-Wen Liang, 楊志仁, 洪仁宇* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38卷(10期):1001-1011頁
(IF: 2.996, 領域排名: 97, 領域期刊數: 139, 領域排名: 69.78%)

Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.
En-Chi Hsu, Kuan-Li Wu, Ying-Ming Tsai, Mei-Hsuan Lee, Ming-Ju Tsai, Chia-Yu Kuo, Yu-Chuan Liu, Fu-Wen Liang, Chih-Jen Yang, Jen-Yu Hung* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(10):1001-1011
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

23

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma.
張昭元, Yung-Chi Huang, 姜宏興, Yu-Yuan Wu, 吳寬澧, 張永裕, 劉怜秀, 蔡英明*, 許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022 24卷(1期):431頁
(IF: 6.208, 領域排名: 69, 領域期刊數: 296, 領域排名: 23.31%)

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma.
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022;24(1):431
(IF: 6.208, Journal Ranking: 69, Number of Journals of this Field: 296, Ranking: 23.31%)

24

Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer.
黃詠琪, 張昭元,吳宇瑗, 吳寬澧, 李孝真,蔡英美, 許雅玲* - - 1 - Cancers - 2022 15卷(1期):176頁
(IF: 0, 領域排名: 0, 領域期刊數: 0, 領域排名: -%)

Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer.
Huang YC, Chang CY, Wu YY, Wu KL, Tsai YM, Lee HC, Tsai EM, Hsu YL. - - 1 - Cancers - 2022;15(1):176
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

25

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer
莊政皓,陳筱伶#,張秀美,蔡毓真,吳寬澧,陳宜樺,陳功超,李瑞英,張詠婕,陳金鈴,杜裕康,洪仁宇,楊志仁*,鍾飲文* - - 1 - cancers - CANCERS 2021 13卷(8期):1966頁
(IF: 6.639, 領域排名: 51, 領域期刊數: 242, 領域排名: 21.07%)

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer
Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, Yu-Chen Tsai , Kuan-Li Wu , I-Hua Chen , Kung-Chao Chen, Jui-Ying Lee , Yong-Chieh Chang , Chin-Ling Chen , Yu-Kang Tu , Jen-Yu Hung , Chih-Jen Yang , Inn-Wen Chong - - 1 - cancers - CANCERS 2021;13(8):1966
(IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%)

26

Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
許朝欽,許瑞峰,吳寬澧* - - 0 - Respirology case reports - 2021 9卷(6期):e00753頁
(IF: 0, 領域排名: 0, 領域期刊數: 0, 領域排名: -%)

Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
Chao-Chin Hsu,Jui-Feng Hsu,Kuan-Li Wu - - 0 - Respirology case reports - 2021;9(6):e00753
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

27

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma.
顏孟畿,吳寬澧,劉又瑋,張永裕,張昭元,洪仁宇,蔡英明*,許雅玲 - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021 10卷(5期):378頁
(IF: 5.079, 領域排名: 16, 領域期刊數: 93, 領域排名: 17.20%)

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
Meng-Chi Yen,Kuan-Li Wu,Yu-Wei Liu,Yung-Yun Chang,Chao-Yuan Chang,Jen-Yu Hung,Ying-Ming Tsai,Ya-Ling Hsu - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021;10(5):378
(IF: 5.079, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

28

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
張昭元, 吳寬澧, 張永裕, 劉又瑋, 黃永琪, 簡淑芳, 林依宣, 蔡珮熏, 洪仁宇, 蔡英明*, 許雅玲 - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021 11卷(6期):578頁
(IF: 4.945, 領域排名: 15, 領域期刊數: 108, 領域排名: 13.89%)

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
Chao-Yuan Chang, Kuan-Li Wu , Yung-Yun Chang , Yu-Wei Liu, Yung-Chi Huang, Shu-Fang Jian, Yi-Shiuan Lin, Pei-Hsun Tsai, Jen-Yu Hung, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021;11(6):578
(IF: 4.945, Journal Ranking: 15, Number of Journals of this Field: 108, Ranking: 13.89%)

29

Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer.
張昭元, 吳寬澧, 張永裕, 蔡珮薰, 洪仁宇, 張維安, 簡淑芳, 黃永琪, 鍾飲文, 蔡英明*, 許雅玲 - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021 46卷(3期):203頁
(IF: 3.906, 領域排名: 133, 領域期刊數: 242, 領域排名: 54.96%)

Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer.
Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, Pei-Hsun Tsai, Jen-Yu Hung, Wei-An Chang, Shu-Fang Jian, Yung-Chi Huang, Inn-Wen Chong, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021;46(3):203
(IF: 3.906, Journal Ranking: 133, Number of Journals of this Field: 242, Ranking: 54.96%)

30

The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.
Yen-Hsiang Huang#, 洪仁宇#, How-Wen Ko#, Po-Lan Su#, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, 吳寬澧, Cheng-Ta Yang, 蘇五洲, Yi-Chun Chu, 王金洲, 廖唯昱, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang - - 1 - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021 13卷(0期):17588359211018022頁
(IF: 8.168, 領域排名: 15, 領域期刊數: 242, 領域排名: 6.20%)

The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, Kuan-Li Wu, Cheng-Ta Yang, Wu-Chou Su, Yi-Chun Chu, Chin-Chou Wang, Wei-Yu Liao, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang - - 1 - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021;13(0):17588359211018022
(IF: 8.168, Journal Ranking: 15, Number of Journals of this Field: 242, Ranking: 6.20%)

31

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
吳寬澧,陳筱伶#,蔡英明,李岱晃,張秀美,蔡毓真,莊政皓,張詠婕,杜裕康,楊志仁*,洪仁宇,鍾飲文* - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021 10卷(19期):4376頁
(IF: 4.241, 領域排名: 39, 領域期刊數: 169, 領域排名: 23.08%)

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, Tai-Huang Lee, Hsiu-Mei Chang, Yu-Chen Tsai, Cheng-Hao Chuang, Yong-Chieh Chang, Yu-Kang Tu, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021;10(19):4376
(IF: 4.241, Journal Ranking: 39, Number of Journals of this Field: 169, Ranking: 23.08%)

32

miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells.
張維安, 蔡明儒, 洪仁宇, 吳寬澧, 蔡英明, 黃永琪, 張昭元, 蔡珮熏, 許雅玲* - - 1 - CANCERS - CANCERS 2021 13卷(24期):6252頁
(IF: 6.639, 領域排名: 51, 領域期刊數: 242, 領域排名: 21.07%)

miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells.
Wei-An Chang, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Ya-Ling Hsu* - - 1 - CANCERS - CANCERS 2021;13(24):6252
(IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%)

33

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer.
蔡英明,吳寬澧, 劉又瑋, 黃詠麒,張昭元, 蔡佩熏,Szi-Hui Liao, 洪仁宇, 許雅玲* - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021 11卷(0期):696931頁
(IF: 6.244, 領域排名: 62, 領域期刊數: 242, 領域排名: 25.62%)

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer.
Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, Wei-An Chang, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Szi-Hui Liao, Jen-Yu Hung, Ya-Ling Hsu - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021;11(0):696931
(IF: 6.244, Journal Ranking: 62, Number of Journals of this Field: 242, Ranking: 25.62%)

34

半胱氨酸白三烯途徑與癌症
蔡明儒,張維安,莊政皓,吳寬澧,鄭至宏,許超群,洪仁宇* - - 1 - Int J Mol Sci - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021 23卷(1期):120頁
(IF: 5.924, 領域排名: 67, 領域期刊數: 295, 領域排名: 22.71%)

Cysteinyl Leukotriene Pathway and Cancer
Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - Int J Mol Sci - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021;23(1):120
(IF: 5.924, Journal Ranking: 67, Number of Journals of this Field: 295, Ranking: 22.71%)

35

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer.
蔡英明,吳寬澧,張永裕,洪仁宇,張維安,張昭元,簡淑芳,蔡珮薰,黃永琪,鍾飲文,許雅玲* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21卷(5期):E1640頁
(IF: 4.556, 領域排名: 74, 領域期刊數: 297, 領域排名: 24.92%)

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer.
Ying-Ming Tsai , Kuan-Li Wu , Yung-Yun Chang , Jen-Yu Hung , Wei-An Chang , Chao-Yuan Chang , Shu-Fang Jian , Pei-Hsun Tsai , Yung-Chi Huang , Inn-Wen Chong , Ya-Ling Hsu* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(5):E1640
(IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%)

36

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
蔡英明,吳寬澧,張永裕,張維安,黃永琪,簡淑芳,蔡珮薰,林依宣,鍾飲文,洪仁宇*,許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21卷(14期):5081頁
(IF: 4.556, 領域排名: 74, 領域期刊數: 297, 領域排名: 24.92%)

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2 alpha Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
Ying-Ming Tsai,Kuan-Li Wu ,Yung-Yun Chang ,Wei-An Chang ,Yung-Chi Huang ,Shu-Fang Jian ,Pei-Hsun Tsai ,Yi-Shiuan Lin ,Inn-Wen Chong ,Jen-Yu Hung ,* Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(14):5081
(IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%)

37

Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma.
陳筱伶,杜裕康,張秀美,李岱晃,吳寬澧,蔡毓真,李玫萱*,楊志仁*,洪仁宇,鐘飲文 - - 1 - Cancers - CANCERS 2020 12卷(12期):3629頁
(IF: 6.126, 領域排名: 37, 領域期刊數: 244, 領域排名: 15.16%)

Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma.
Hsiao-Ling Chen,Yu-Kang Tu,Hsiu-Mei Chang,Tai-Huang Lee,Kuan-Li Wu,Yu-Chen Tsai,Mei-Hsuan Lee,Chih-Jen Yang,Jen-Yu Hung,Inn-Wen Chong - - 1 - Cancers - CANCERS 2020;12(12):3629
(IF: 6.126, Journal Ranking: 37, Number of Journals of this Field: 244, Ranking: 15.16%)

38

利用CHADS2及CHA2DS2ASc和ABCD分數以預測睡眠呼吸中止症病人周邊動脈疾病的發生
吳寬澧,郭家佑,蔡毓真,洪仁宇,許超群,楊志仁,徐崇堯,吳孟霓,蔡明儒* - - 1 - Journal of Clinical Medicine - JOURNAL OF CLINICAL MEDICINE 2019 8卷(2期):8(2). pii: E188頁
(IF: 5.688, 領域排名: 15, 領域期刊數: 160, 領域排名: 9.38%)

CHADS2, CHA2DS2ASc, and New ABCD Scores Predict the Risk of Peripheral Arterial Disease in Patients with Sleep Apnea
Wu K-L, Kuo C-Y, Tsai Y-C, Hung J-Y, Sheu C-C, Yang C-J, Hsu C-Y, Wu M-N, Tsai M-J - - 1 - Journal of Clinical Medicine - JOURNAL OF CLINICAL MEDICINE 2019;8(2):8(2). pii: E188
(IF: 5.688, Journal Ranking: 15, Number of Journals of this Field: 160, Ranking: 9.38%)

39

The Roles of MicroRNA in Lung Cancer
吳寬澧,蔡英明, 連啟惇,郭柏麟,洪仁宇* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019 20卷(7期):1611頁
(IF: 4.183, 領域排名: 46, 領域期刊數: 172, 領域排名: 26.74%)

The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu, Ying-Ming Tsai , Chi-Tun Lien, Po-Lin Kuo,Jen-Yu Hung - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019;20(7):1611
(IF: 4.183, Journal Ranking: 46, Number of Journals of this Field: 172, Ranking: 26.74%)

 Project

NO
YEAR — Source — No — Type
Project Name
Duration
1
117 — N 國科會(原科技部) — NSTC115-2314-B-037-116-MY3 — 1 個人型
PD-L1 異質性驅動肺鱗狀細胞癌腫瘤微環境重塑與免疫逃逸:多體學策略解析突破性治療標靶(3/3)( )
2028/08/01 ~ 2029/07/31
2
116 — N 國科會(原科技部) — NSTC115-2314-B-037-116-MY3 — 1 個人型
PD-L1 異質性驅動肺鱗狀細胞癌腫瘤微環境重塑與免疫逃逸:多體學策略解析突破性治療標靶(2/3)( )
2027/08/01 ~ 2029/07/31
3
115 — N 國科會(原科技部) — NSTC115-2314-B-037-116-MY3 — 1 個人型
PD-L1 異質性驅動肺鱗狀細胞癌腫瘤微環境重塑與免疫逃逸:多體學策略解析突破性治療標靶(1/3)( )
2026/08/01 ~ 2029/07/31
4
113 — N 國科會(原科技部) — NSTC113-2314-B-037-077 — 1 個人型
肺癌肝轉移及泛免疫檢查點抑制之分子機制探討( )
2024/08/01 ~ 2025/07/31
5
112 — N 國科會(原科技部) — NSTC112-2314-B-037-019 — 1 個人型
利用多體學特徵化肺癌肝轉移之腫瘤異質性及微環境( )
2023/08/01 ~ 2024/07/31
6
111 — N 國科會(原科技部) — MOST110-2314-B-037-126-MY2 — 1 個人型
探索新穎標靶基因HS6ST2在肺鱗狀細胞癌的發展(2/2)( )
2022/08/01 ~ 2023/07/31
7
110 — N 國科會(原科技部) — MOST110-2314-B-037-126-MY2 — 1 個人型
探索新穎標靶基因HS6ST2在肺鱗狀細胞癌的發展(1/2)( )
2021/08/01 ~ 2023/07/31

 Patent